What does the evidence say about Pterostilbene Blood Pressure Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Pterostilbene Blood Pressure Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Reduced estradiol levels have been associated with undesirable symptoms of the menopause transition. [Holmes HE (2026); evidence level 2] - As anticipated NRPT intake significantly increased urinary levels of methyl-nicotinamide (Me-NAM) as well as the methylated pyridone carboxamides (Me-PYs) in all groups. [Holmes HE (2026); evidence level 2] - Introduction Nicotinamide adenine dinucleotide (NAD+) is a metabolite of vitamin B3 necessary for the production of key hormones like estradiol. [Holmes HE (2026); evidence level 2] - Prospective cohort studies and randomized controlled trials suggest that higher intakes of anthocyanin-rich foods are associated with improved vascular function, lower blood pressure, and reduced risk of coronary events and CVD [,,,,,,]. [Jurja Sanda (2025); evidence level 3] - Clinical trials in various populations, ranging from healthy individuals to those with metabolic syndrome or elevated cardiometabolic risk, have reported improvements in surrogate markers of vascular health—including flow-mediated dilation (FMD), blood pressure, arterial stiffness, and circulating biomarkers of endothelial activation—after blueberry intake [,,,,,,,,,,,]. [Jurja Sanda (2025); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.